FDA Approves High Dose Regimen of SPINRAZA for People Living with SMA
PR Newswire —
SCHAUMBURG, Ill., March 30, 2026 /PRNewswire/ -- Cure SMA, the leading nonprofit organization supporting those impacted by spinal muscular atrophy (SMA), celebrates that Biogen today announced FDA approval of the High Dose regimen of SPINRAZA™ (nusinersen) to treat people living with SMA....